Crescent Biopharma, Inc. Common Stock CBIO

$14.07 +4.22% at last close

Recent SEC Filings

FormDescriptionFiledDocument
8-K 8-K 2026-10-15 View →
4 FORM 4 2026-09-18 View →
4 FORM 4 2026-09-18 View →
4 FORM 4 2026-09-18 View →
4 FORM 4 2026-09-18 View →
4 FORM 4 2026-09-18 View →
4 FORM 4 2026-09-18 View →
4 FORM 4 2026-09-18 View →
10-Q 10-Q 2026-07-30 View →
8-K 8-K 2026-07-30 View →
4 OWNERSHIP DOCUMENT 2026-07-20 View →
8-K 8-K 2026-07-15 View →
424B5 424B5 2026-07-15 View →
8-K 8-K 2026-07-14 View →
424B5 424B5 2026-07-14 View →
S-3 S-3 2026-07-01 View →
4 FORM 4 2026-06-23 View →
4 FORM 4 2026-06-23 View →
4 FORM 4 2026-06-23 View →
4 FORM 4 2026-06-23 View →
4 FORM 4 2026-06-23 View →
4 FORM 4 2026-06-23 View →
4 FORM 4 2026-06-23 View →
4 FORM 4 2026-06-03 View →
4 FORM 4 2026-06-03 View →
4 FORM 4 2026-06-03 View →
4 FORM 4 2026-06-03 View →
4 FORM 4 2026-06-03 View →
8-K 8-K 2026-06-03 View →
8-K 8-K 2026-04-29 View →
10-Q 10-Q 2026-04-29 View →
DEF 14A DEF 14A 2026-04-21 View →
8-K 8-K 2026-02-26 View →
10-K 10-K 2026-02-26 View →
S-1 S-1 2026-01-07 View →
4 FORM 4 2025-12-17 View →
4 FORM 4 2025-12-17 View →
4 FORM 4 2025-12-17 View →
4 FORM 4 2025-12-17 View →
4 FORM 4 2025-12-17 View →

Filings are sourced directly from the SEC's EDGAR system. Annual reports (10-K) and quarterly reports (10-Q) carry the full financial statements; 8-K filings disclose material events between reports; Form 4 filings record insider purchases and sales.

Key Stats

Last Close
$14.07
Market Cap
$501.48 million
52-Week Range
$8.72 – $27.41
Average Volume
437K shs

Data is delayed and provided for informational purposes only. Not investment advice. See our disclaimer.